For the first time ever in the UK, postmenopausal women will be able to access Gina 10 microgram vaginal tablets without requiring a prescription.

Dr Paula Briggs, Chair, British Menopause Society said: “The BMS welcomes the introduction of this product which is likely to improve women’s access to treatment. Estradiol vaginal tablets have been available on prescription for over 30 years and have a wealth of efficacy and safety data. Urogenital atrophy is one of the most common challenges women face after the menopause and this reclassification means they can now access a low dose vaginal oestrogen which treats the underlying cause of vaginal atrophy, at their local pharmacy.”

For the full press release click here.